The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer
Clinical trial NCT07704645 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07704645
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-06-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.